iBio, Inc. IBIO

1.19 (0.01) (0.83%) as of 25 Sep
Market cap
$77.3M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22 Jun '23 Jun '24 Jun '25 Jun '26
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 0.00 0.00
P/S ratio
88.10 20.87 6.57 85.11 124.60 27.63 — 3.80 12.77 269.79
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 0.00 0.00
P/Operating CF
(9.22) (2.75) (3.02) (36.05) (40.88) (4.93) — (1.59) (1.73) (29.24)
P/B ratio
3.89 0.57 5.40 2.46 2.72 0.89 — 0.36 0.54 2.12
Price to Tangible BV
4.89 0.64 12.25 2.51 2.75 0.97 — 0.48 0.99 2.17
EV/Sales
131.23 41.03 16.61 71.56 97.50 24.77 — (2.94) 1.39 141.38
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 — 0.39 0.00 0.00
EV/Operating CF
(3.93) (1.35) (2.40) (8.78) (7.69) (1.36) — 0.32 (0.06) (4.11)
EV/FCF
(3.50) (1.25) (2.24) (8.00) (6.56) (1.03) — 0.31 (0.05) (3.94)
Quick Ratio
4.10 7.87 1.31 11.60 15.43 1.30 0.34 4.07 1.42 7.59
Current Ratio
4.26 8.00 1.39 11.79 15.74 1.48 1.19 4.08 1.59 7.85
Net Debt/EBITDA
(1.36) (0.73) (1.46) 1.89 2.26 0.31 (0.23) 0.89 0.44 2.57
Debt/Assets
70.16% 58.22% 81.36% 34.94% 22.26% 25.83% 33.22% 4.45% 3.58% 0.00%
Debt/Equity
2.83 1.55 10.13 0.58 0.30 0.40 0.89 0.06 0.06 0.00
Asset Turnover
0.01 0.01 0.05 0.03 0.02 0.02 0.00 0.01 0.02 0.00
Operating CF/Net income
0.90 0.82 0.78 0.35 1.28 0.74 0.47 0.74 0.83 0.70
Capex/Depreciation
(0.95) (0.63) (0.57) (0.51) (1.96) (2.76) (1.86) 0.66 (0.01) (0.69)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(88.73%) (130.51%) (191.75%) (129.55%) (28.41%) (58.58%) (164.86%) (135.71%) (101.52%) (65.70%)
ROA
(33.38%) (41.38%) (48.47%) (61.33%) (19.46%) (40.91%) (92.47%) (71.22%) (70.79%) (54.04%)
ROIC
(34.19%) (35.13%) (43.05%) (25.44%) (43.88%) (33.36%) (84.34%) (135.39%) (163.11%) 0.00%
Return on Tangible Assets
(45.48%) (41.53%) (69.39%) (63.59%) (22.02%) (314.81%) (776.80%) (161.06%) (271.13%) (39.54%)
Average Days of Receivables
162.12 61.66 17.54 1,253.21 850.69 1,181.79 0.00 1,156.64 95.81 4,029.60
Research and Development Expense of Revenue
1,044.92% 897.75% 271.26% 218.13% 421.30% 521.60% 0.00% 2,304.44% 2,078.00% 19,643.00%
Selling, General and Administrative Expense of Revenue
2,677.92% 2,406.53% 611.10% 693.83% 929.19% 1,154.67% 0.00% 5,188.44% 2,672.50% 10,595.00%
Intangible Assets out of Total Assets
0.05 0.04 0.04 0.01 0.01 0.05 0.13 0.19 0.30 0.02
Share Based Compensation of Revenue
256.35% 173.42% 11.94% 23.69% 66.89% 232.32% 0.00% 905.78% 382.50% 1,373.00%
Graham Net Nets
(0.53) (1.15) (1.76) 0.17 0.22 0.16 — 1.07 0.18 0.43
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 0.00 0.00
Earnings Yield
(41.03%) (166.85%) (133.46%) (38.64%) (8.61%) (87.75%) — (323.22%) (228.95%) (19.43%)
Free Cash Flow Yield
(42.51%) (157.13%) (112.82%) (10.50%) (11.92%) (86.62%) — (247.80%) (199.23%) (13.30%)
Revenue per Share
22.13 20.85 53.25 13.04 6.06 4.32 0.00 0.06 0.04 0.00
Operating CF per Share
(739.49) (632.86) (368.73) (106.25) (76.83) (85.94) (49.73) (4.84) (1.46) (0.22)
Capex per Share
(89.49) (50.66) (26.12) (9.19) (13.19) (26.67) (5.13) 0.24 0.00 (0.01)
Free Cash Flow per Share
(828.99) (683.52) (394.85) (115.44) (90.02) (112.61) (54.86) (4.61) (1.46) (0.23)
Cash per Share
454.38 748.08 116.65 438.79 247.83 76.87 11.97 3.90 0.82 0.85
Shareholders Equity per Share
500.84 758.87 64.83 450.69 277.45 145.57 25.13 5.57 1.42 0.82
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
500.84 758.87 64.83 450.69 277.45 145.57 25.13 5.57 1.42 0.82
Free Cash Flow
(14.76) (14.56) (14.96) (14.50) (35.23) (49.11) (33.57) (17.65) (15.32) (23.80)
Working Capital
6.56 14.25 1.35 56.51 97.95 14.63 4.15 11.83 3.62 80.48
Capital Expenditures
(1.59) (1.08) (0.99) (1.15) (5.16) (11.63) (3.14) 0.91 (0.02) (0.58)
Net Current Asset Value
(18.52) (10.63) (23.32) 24.17 66.20 9.15 0.43 8.26 1.42 78.82
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 — 0.36 0.00 0.00
Capex to Sales
4.04 2.43 0.49 0.70 2.18 6.17 0.00 (4.03) 0.04 5.78
Net Profit Margin
(3,711.17%) (3,685.81%) (884.69%) (2,335.78%) (989.75%) (2,674.68%) 0.00% (11,069.78%) (4,594.25%) (33,044.00%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.07 0.07 0.07 0.61 0.30 3.07 0.40 0.38 0.36 0.27
Cash ROIC
(91.68%) (67.56%) (120.76%) (11.76%) (16.24%) (31.67%) (95.22%) (59.12%) (76.02%) (15.14%)
Accounts Receivable Turnover
1.01 3.55 23.47 0.57 0.43 0.32 0.00 0.49 0.98 0.17
Accounts Payable Turnover
0.00 0.00 0.00 0.51 0.73 1.16 0.36 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 — 1.71 3.54 1.93 0.00 — — —
Average Days of Payables
0.00 0.00 0.00 913.28 562.73 410.54 610.20 0.00 0.00 0.00
Days of Inventory on Hand
0.00 0.00 — 414.32 6.74 375.49 0.00 — — —
Average Receivables
0.39 0.13 0.09 2.86 5.58 5.81 3.15 0.46 0.41 0.60
Average Payables
0.96 0.77 0.90 1.38 2.01 3.26 3.06 1.10 1.27 3.31
Average Inventory
0.02 0.03 — 0.41 0.41 1.96 — — — —
Average Assets
43.81 39.55 36.83 62.39 120.58 123.19 70.31 34.97 25.96 61.15
Average Common Equity
16.48 12.54 9.31 29.53 82.59 86.03 39.43 18.35 18.10 50.30

Fold the line items

Columns are period end dates